Job title: Associate Professor, Interventional Cardiologist
Salvatore Brugaletta, MD, PhD, is Associate Professor at the University of Barcelonaand Interventional Cardiologist at the Hospital Clinic, Barcelona, Spain,with a large experience in coronary and structural heart disease (Intracoronary imaging, complex heart disease, left main, bifurcation, STEMI, cardiogenic shock, CHIP, TAVI, Mitraclip, LAA, etc). Highly skilled in Clinical Research, Medical…
View more
Author(s):
Amer M Johri,
Matthew I Crerar,
Anthony J Sanfilippo
Added:
3 years ago
Abstract
The assessment of left ventricular ejection fraction is a key clinical investigation guiding the diagnosis, management and prognosis of cardiology patients. Echocardiography is an inexpensive, safe, and portable method commonly used to provide this information. Improvement in the quality of assessment provided by echocardiography continues to be the subject of current clinical programs…
View more
Author(s):
Marco Valgimigli
Added:
5 years ago
Prof Marco Valgimigli discusses the MATRIX trial, filmed by Radcliffe Cardiology on site in Munich, ESC 2018.
View more
Author(s):
Francesco Lavarra
Added:
3 years ago
True coronary bifurcations (Medina 1,1,1 and most of 1,0,1 and 0,1,1) with side branch (SB) diameter of >2.25 mm and lesion length of >10 mm are likely to require two-stent treatment techniques (Figure 1A).1,2 The Crush technique underwent a series of technical iterations and modifications by Chen et al. before evolving into the so-called mini double kissing Crush (DK-Crush) technique.3,4
…
View more
Author(s):
Firas Zahr
Added:
2 years ago
In this video interview, Dr Firas Zahr (OHSU Hospital, Portland, OR, US) outlines the 30-day outcomes of the Intrepid TMVR Early Feasibility Study, originally presented at TCT 2021. This was a prospective multicenter trial, designed to study the feasibility of the Intrepid TMVR System. At 30 days, findings show favourable haemodynamics and an improved NYHA class in patients with mitral…
View more